Injective Protocol’s inEVM Nears Completion, Bridging Ethereum and Low-Fee Derivatives Trading

Injective Protocol Nears Completion of inEVM, Boosting Ethereum Integration

The Injective Protocol, a decentralized exchange (DEX) platform specializing in derivatives, has made a major announcement that its Injective Ethereum Virtual Machine (inEVM) is now nearing completion, with progress reaching an impressive 98%. The inEVM is poised to play a pivotal role in bridging the gap between the highly scalable and cost-effective Injective Protocol and Ethereum, ultimately empowering traders to execute swaps with significantly reduced fees.